2-N-[2-[di(propan-2-yl)amino]ethyl]-4-N,4-N-diethyl-6-(4-pyridin-2-ylpiperazin-1-yl)-1,3,5-triazine-2,4-diamine
C24H41N9 — CID 117089791
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-N-[2-[di(propan-2-yl)amino]ethyl]-4-N,4-N-diethyl-6-(4-pyridin-2-ylpiperazin-1-yl)-1,3,5-triazine-2,4-diamine
2-N-[2-[di(propan-2-yl)amino]ethyl]-4-N,4-N-diethyl-6-(4-pyridin-2-ylpiperazin-1-yl)-1,3,5-triazine-2,4-diamine (PubChem CID 117089791) has the molecular formula C24H41N9 and a molecular weight of 455.66 g/mol. Its IUPAC name is 2-N-[2-[di(propan-2-yl)amino]ethyl]-4-N,4-N-diethyl-6-(4-pyridin-2-ylpiperazin-1-yl)-1,3,5-triazine-2,4-diamine.
Molecular Properties
| Compound Name | 2-N-[2-[di(propan-2-yl)amino]ethyl]-4-N,4-N-diethyl-6-(4-pyridin-2-ylpiperazin-1-yl)-1,3,5-triazine-2,4-diamine |
|---|---|
| PubChem CID | 117089791 |
| Molecular Formula | C24H41N9 |
| Molecular Weight | 455.66 g/mol |
| Exact Mass | 455.35 |
| IUPAC Name | 2-N-[2-[di(propan-2-yl)amino]ethyl]-4-N,4-N-diethyl-6-(4-pyridin-2-ylpiperazin-1-yl)-1,3,5-triazine-2,4-diamine |
| SMILES | CCN(CC)c1nc(NCCN(C(C)C)C(C)C)nc(N2CCN(c3ccccn3)CC2)n1 |
| InChI | InChI=1S/C24H41N9/c1-7-30(8-2)23-27-22(26-13-14-33(19(3)4)20(5)6)28-24(29-23)32-17-15-31(16-18-32)21-11-9-10-12-25-21/h9-12,19-20H,7-8,13-18H2,1-6H3,(H,26,27,28,29) |
| InChIKey | PGADGBNECRUEOK-UHFFFAOYSA-N |
| XLogP | 2.97 |
| TPSA | 76.55 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 11 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 455.66 |
| LogP ≤ 5 | 2.97 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 117089791 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.